Avanir Pharmaceuticals

Organization DescriptionAVANIR Pharmaceuticals is a biopharmaceutical drug discovery and development company engaged in research, discovery, development and licensing of innovative drug products and, through its subsidiary Xenerex Biosciences, antibody generation services. The Company’s lead product, Abreve™, (docosanol 10% cream) was approved by the U.S. Food and Drug Administration (FDA) in July 2000, making it the first and only FDA-approved cold sore treatment available without a prescription.